Table 1.

Summary of the healthy controls and Alzheimer’s disease (AD) induced pluripotent stem cell (iPSC) lines used in this study.

iPSCs Name	Status	AD Risk Variant	Age	Age at Onset	Gender	APOE Genotype	Reference
CON8	Control individual	Control	69	-	M	3/4	[43]
CON9	Control individual	Control	75	-	F	3/3	[40]
AD-2-2	AD patient	TREM2 p.R47H heterozygous	65	60	M	4/4	[42]
AD-2-4	AD patient	TREM2 p.R47H heterozygous	67	64	F	2/4	[41]